Global Cancer Biomarkers Market Analysis Report 2022-2026: Increased Recognition of Personalized Medicine & Growing Application Areas of Companion Diagnostics
22 avr. 2022 04h23 HE
|
Research and Markets
Dublin, April 22, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Biomarkers Market by Type (Protein, Genetic), Cancer (Lung, Breast, Leukemia, Melanoma, Colorectal), Profiling Technology (Omics,...
Liquid Biopsy Market, 2027
17 sept. 2020 05h58 HE
|
Research and Markets
Dublin, Sept. 17, 2020 (GLOBE NEWSWIRE) -- The "Global Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional &...
Crown Bioscience Announces San Diego, CA Site Expansion
09 mai 2019 08h30 HE
|
Crown Bioscience
SAN DIEGO, May 09, 2019 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation,...
Crown Bioscience Creates Center of Excellence for Bioinformatics, Big Data, and Biomarker Discovery Services
18 déc. 2018 08h30 HE
|
Crown Bioscience
SAN DIEGO, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation,...
中美冠科生物技术有限公司（CrownBio）创建生物信息学、大数据和生物标志发现解决方案卓越中心
17 déc. 2018 19h30 HE
|
Crown Bioscience
加州圣地亚哥, Dec. 18, 2018 (GLOBE NEWSWIRE) -- 中美冠科生物技术有限公司（CrownBio）是一家全球药物研发解决方案公司，提供推动肿瘤学、炎症、心血管和代谢疾病研究的移植平台，日前宣布在中国江苏苏州新建分公司，扩大现有移植肿瘤研究的能力。 ...
Crown Bioscience Creates Center of Excellence for Bioinformatics, Big Data, and Biomarker Discovery Services
17 déc. 2018 19h30 HE
|
Crown Bioscience
SAN DIEGO, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation,...
Exosome Diagnostics Partners with Intezyne to Develop Exosomal RNA-based Assay for Novel Cancer Resistance Pathway (CRP) Inhibitor
14 mars 2018 07h30 HE
|
Exosome Diagnostics
Boston, MA, March 14, 2018 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc., a market leader in liquid biopsy and the world’s first exosome-based diagnostics company announces a collaboration...
Darin Leigh Joins Metabolon as Chief Commercial Officer
06 juil. 2015 11h18 HE
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., July 6, 2015 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announces that Darin Leigh has been appointed Chief Commercial Officer, a new...